SCHEMBL21150182

SCHEMBL21150182

C=C/C=C\c1oc2ccc(-c3c4ccccc4c(-c4cccc(-c5ccc6ccccc6c5)c4)c4ccccc34)cc2c1C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK9 P50750 1/20 0.35
DYRK1A Q13627 1/20 0.35
DYRK2 Q92630 1/20 0.35
ALDH1A1 P00352 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HSD17B10 Q99714 1/20 0.33
PLA2G2A P14555 2/20 0.33
PLA2G4A P47712 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
PLA2G10 O15496 1/20 0.33
PGR P06401 2/20 0.32
HSD17B1 P14061 1/20 0.32
HSD17B2 P37059 1/20 0.32
MTOR P42345 1/20 0.32
UTRN P46939 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25120354 0.93 PGR (0.35) CDK9DYRK1ADYRK2ALDH1A1CYP1A2
SCHEMBL24961104 0.91 PLA2G2A (0.38) CDK9DYRK1ADYRK2ALDH1A1CYP1A2
SCHEMBL24117556 0.88 MAOA (0.36) CDK9DYRK1ADYRK2ALDH1A1CYP1A2
SCHEMBL22063393 0.87 L3MBTL1 (0.36) CDK9DYRK1ADYRK2ALDH1A1CYP1A2
SCHEMBL22356518 0.87 PLA2G2A (0.38) CDK9DYRK1ADYRK2ALDH1A1CYP1A2
SCHEMBL23919327 0.85 MAOA (0.37) CDK9DYRK1ADYRK2ALDH1A1CYP1A2
SCHEMBL24393635 0.85 CYP1A1 (0.32) ALDH1A1CYP1A2CYP3A4CYP2C9HPGD
SCHEMBL24718901 0.84 PLA2G2A (0.36) CDK9DYRK1ADYRK2ALDH1A1CYP1A2
SCHEMBL22766735 0.84 MAOA (0.36) CDK9DYRK1ADYRK2ALDH1A1CYP1A2
SCHEMBL22063087 0.84 MAOA (0.38) CDK9DYRK1ADYRK2ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11839153-B2 Compound, material for organic electroluminescent element, organic electroluminescent element, and electronic device IDEMITSU KOSAN CO.,LTD. (JP) 2023-12-05 US disclosed
US-20220393113-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-08 US disclosed
US-11139437-B2 Compound and organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2021-10-05 US disclosed
US-20200388767-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2020-12-10 US disclosed
US-20200266361-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2020-08-20 US disclosed
US-20190214579-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2019-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11139437-B2 Compound and organic electroluminescence device RIF1, OR10J3, LEF1 CDK9 1768/4885DYRK1A 4337/4885DYRK2 4410/4885
US-11839153-B2 Compound, material for organic electroluminescent element, organic electroluminescent element, and electronic device RER1, RPS19, RPL19 CDK9 373/4885DYRK1A 4109/4885DYRK2 4188/4885
US-20200266361-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE RER1, RPS19, RPL19 CDK9 373/4885DYRK1A 4109/4885DYRK2 4188/4885
US-20190214579-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE PIEZO1, RIF1, OR10J3 CDK9 1666/4885DYRK1A 4390/4885DYRK2 4424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.